These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2457063)

  • 1. Use of serum-free, compositionally defined medium for analysis of macrophage differentiation in vitro.
    Vogel SN; Perera PY; Hogan MM; Majde JA
    J Leukoc Biol; 1988 Aug; 44(2):136-42. PubMed ID: 2457063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow-derived macrophages: development and regulation of differentiation markers by colony-stimulating factor and interferons.
    Warren MK; Vogel SN
    J Immunol; 1985 Feb; 134(2):982-9. PubMed ID: 2578168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of assay medium composition on macrophage-mediated tumor cell binding and lysis.
    Hasday JD; Crawford EK
    J Immunol Methods; 1988 Nov; 114(1-2):243-52. PubMed ID: 3141516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of murine macrophage Fc receptor-dependent phagocytosis and antibody-dependent cellular cytotoxicity during in vitro culture with interferons-gamma, alpha/beta and/or fetal bovine serum.
    Leu RW; Rummage JA; Horn MJ
    Immunobiology; 1989 Feb; 178(4-5):340-50. PubMed ID: 2469639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor.
    Falk LA; Wahl LM; Vogel SN
    J Immunol; 1988 Apr; 140(8):2652-60. PubMed ID: 3128601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic evidence for the requirement of protein kinase C in IFN-induced macrophage Fc gamma receptor and Ia antigen expression.
    Politis AD; Vogel SN
    J Immunol; 1990 Dec; 145(11):3788-95. PubMed ID: 1700995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow progenitors cultured in the presence of granulocyte-macrophage colony-stimulating factor versus macrophage colony-stimulating factor differentiate into macrophages with distinct tumoricidal capacities.
    Falk LA; Hogan MM; Vogel SN
    J Leukoc Biol; 1988 May; 43(5):471-6. PubMed ID: 3131473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
    Hogan MM; Vogel SN
    J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A commercially available serum-free medium appropriate for studies of macrophage functions in vitro.
    Majde JA
    J Immunol Methods; 1988 Nov; 115(1):89-93. PubMed ID: 2973495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha induces increased hydrogen peroxide production and Fc receptor expression, but not increased Ia antigen expression by peritoneal macrophages.
    Hoffman M; Weinberg JB
    J Leukoc Biol; 1987 Dec; 42(6):704-7. PubMed ID: 3316463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of class II MHC determinants on macrophages by IFN-gamma and IL-4.
    Cao H; Wolff RG; Meltzer MS; Crawford RM
    J Immunol; 1989 Dec; 143(11):3524-31. PubMed ID: 2479682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Cyclodextrin as a substitute for fetal calf serum in the primary antibody response in vitro.
    Ohmori H; Yamamoto I
    Eur J Immunol; 1987 Jan; 17(1):79-83. PubMed ID: 3816937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function.
    Fischer HG; Frosch S; Reske K; Reske-Kunz AB
    J Immunol; 1988 Dec; 141(11):3882-8. PubMed ID: 3141506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing effects of glucocorticoids on interferon-gamma-induced murine macrophage Fc receptor and Ia antigen expression.
    Warren MK; Vogel SN
    J Immunol; 1985 Apr; 134(4):2462-9. PubMed ID: 3919097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of macrophage populations. IV. Modulation of Ia expression in bone marrow-derived macrophages.
    Calamai EG; Beller DI; Unanue ER
    J Immunol; 1982 Apr; 128(4):1692-4. PubMed ID: 6801119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of mouse serum and the presence of non-adherent cells for the culture of mouse macrophages.
    Grace S; Guthrie LA; Johnston RB
    J Immunol Methods; 1988 Nov; 114(1-2):21-6. PubMed ID: 3183392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fetal calf serum on cytokine release by bone marrow-derived macrophages during infection with intracellular bacteria.
    Flesch IE; Kaufmann SH
    Immunobiology; 1999 Feb; 200(1):120-7. PubMed ID: 10084700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between murine macrophage Fc receptor-mediated phagocytic function and competency for activation for non-specific tumor cytotoxicity.
    Leu RW; Rummage JA; Rahimi MB; Herriott MJ
    Immunobiology; 1986 Apr; 171(3):220-33. PubMed ID: 3519439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of macrophage tumoricidal activity by glucocorticoids.
    Hogan MM; Vogel SN
    J Immunol; 1988 Jan; 140(2):513-9. PubMed ID: 3121748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of macrophage activation by IL-3. I. IL-3 functions as a macrophage-activating factor with unique properties, inducing Ia and lymphocyte function-associated antigen-1 but not cytotoxicity.
    Frendl G; Beller DI
    J Immunol; 1990 May; 144(9):3392-9. PubMed ID: 2158509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.